353 related articles for article (PubMed ID: 25774808)
1. Enhanced functions of peripheral γδ T cells in chronic hepatitis B infection during interferon α treatment in vivo and in vitro.
Chen M; Hu P; Ling N; Peng H; Lei Y; Hu H; Zhang D; Ren H
PLoS One; 2015; 10(3):e0120086. PubMed ID: 25774808
[TBL] [Abstract][Full Text] [Related]
2. Pegylated interferon α enhances recovery of memory T cells in e antigen positive chronic hepatitis B patients.
Liu YZ; Hou FQ; Ding P; Ren YY; Li SH; Wang GQ
Virol J; 2012 Nov; 9():274. PubMed ID: 23158844
[TBL] [Abstract][Full Text] [Related]
3. A possible role for NKT-like cells in patients with chronic hepatitis B during telbivudine treatment.
Diao H; He J; Zheng Q; Chen J; Cui G; Wei Y; Ye P; Kohanawa M; Li L
Immunol Lett; 2014 Jul; 160(1):65-71. PubMed ID: 24718278
[TBL] [Abstract][Full Text] [Related]
4. Enhanced peripheral γδT cells cytotoxicity potential in patients with HBV-associated acute-on-chronic liver failure might contribute to the disease progression.
Chen M; Hu P; Peng H; Zeng W; Shi X; Lei Y; Hu H; Zhang D; Ren H
J Clin Immunol; 2012 Aug; 32(4):877-85. PubMed ID: 22415432
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of SATB1 expression in regulatory T cells contributes to hepatitis B virus-related chronic liver inflammation.
Li XF; Tian L; Wang YY; Kong HS; Dong YJ; Zhu QY; Ni Q; Chen Y
Mol Med Rep; 2015 Jan; 11(1):231-6. PubMed ID: 25338958
[TBL] [Abstract][Full Text] [Related]
6. CD28 family of receptors on T cells in chronic HBV infection: Expression characteristics, clinical significance and correlations with PD-1 blockade.
Tang ZS; Hao YH; Zhang EJ; Xu CL; Zhou Y; Zheng X; Yang DL
Mol Med Rep; 2016 Aug; 14(2):1107-16. PubMed ID: 27314219
[TBL] [Abstract][Full Text] [Related]
7. Taurocholic acid inhibits the response to interferon-α therapy in patients with HBeAg-positive chronic hepatitis B by impairing CD8
Xun Z; Lin J; Yu Q; Liu C; Huang J; Shang H; Guo J; Ye Y; Wu W; Zeng Y; Wu S; Xu S; Chen T; Chen J; Ou Q
Cell Mol Immunol; 2021 Feb; 18(2):461-471. PubMed ID: 33432062
[TBL] [Abstract][Full Text] [Related]
8. Increased Frequencies of Circulating IFN-γ-Producing Vδ1(+) and Vδ2(+) γδ T Cells in Patients with Asymptomatic Persistent Hepatitis B Virus Infection.
Conroy MJ; Mac Nicholas R; Taylor M; O'Dea S; Mulcahy F; Norris S; Doherty DG
Viral Immunol; 2015 May; 28(4):201-8. PubMed ID: 25789722
[TBL] [Abstract][Full Text] [Related]
9. RIG-I enhances interferon-α response by promoting antiviral protein expression in patients with chronic hepatitis B.
Wu S; Lin J; Fu Y; Ou Q
Antivir Ther; 2018; 23(7):575-583. PubMed ID: 29790851
[TBL] [Abstract][Full Text] [Related]
10. In vitro immunomodulatory activity of interferon alpha on toll-like receptor 9 signaling pathway in chronic hepatitis B.
Wang X; Zhao YR; Liu HL; Ma XH; Zhang Y
J Interferon Cytokine Res; 2015 May; 35(5):385-91. PubMed ID: 25535670
[TBL] [Abstract][Full Text] [Related]
11. Hepatitis B virus-specific T-cell proliferation and cytokine secretion in chronic hepatitis B e antibody-positive patients treated with ribavirin and interferon alpha.
Rico MA; Quiroga JA; Subirá D; Castañón S; Esteban JM; Pardo M; Carreño V
Hepatology; 2001 Jan; 33(1):295-300. PubMed ID: 11124848
[TBL] [Abstract][Full Text] [Related]
12. Ribavirin and IFN-alpha combination therapy induces CD4+ T-cell proliferation and Th1 cytokine secretion in patients with chronic hepatitis B.
Ren FY; Jin H; Piao XX; Piao FS
World J Gastroenterol; 2007 Nov; 13(41):5440-5. PubMed ID: 17907286
[TBL] [Abstract][Full Text] [Related]
13. TCRγδ(+)CD4(-)CD8(-) T cells suppress the CD8(+) T-cell response to hepatitis B virus peptides, and are associated with viral control in chronic hepatitis B.
Lai Q; Ma S; Ge J; Huang Z; Huang X; Jiang X; Li Y; Zhang M; Zhang X; Sun J; Abbott WG; Hou J
PLoS One; 2014; 9(2):e88475. PubMed ID: 24551107
[TBL] [Abstract][Full Text] [Related]
14. Hepatitis B virus-specific T-cell responses during IFN administration in a small cohort of chronic hepatitis B patients under nucleos(t)ide analogue treatment.
Sprinzl MF; Russo C; Kittner J; Allgayer S; Grambihler A; Bartsch B; Weinmann A; Galle PR; Schuchmann M; Protzer U; Bauer T
J Viral Hepat; 2014; 21(9):633-41. PubMed ID: 24251783
[TBL] [Abstract][Full Text] [Related]
15. Telbivudine decreases proportion of peripheral blood CD4+CD25+CD127low T cells in parallel with inhibiting hepatitis B virus DNA.
Yan Z; Zhou J; Zhang M; Fu X; Wu Y; Wang Y
Mol Med Rep; 2014 May; 9(5):2024-30. PubMed ID: 24626572
[TBL] [Abstract][Full Text] [Related]
16. [Study on the correlation of the effect of entecavir on Th1/Th2 cytokines level in the treatment of chronic hepatitis].
Li L; Jing YB; Liu J; Wang CL; Liu B
Zhonghua Gan Zang Bing Za Zhi; 2017 Aug; 25(8):606-611. PubMed ID: 29056011
[No Abstract] [Full Text] [Related]
17. Peripheral blood lymphocyte dynamics and viral kinetics in patients with chronic active hepatitis B virus infection treated by tenofovir.
Arasli M; Ustundag Y; Delikanli B; Harmandar F; Buyukuysal C
Hepatogastroenterology; 2012 May; 59(115):851-7. PubMed ID: 22193343
[TBL] [Abstract][Full Text] [Related]
18. The E genotype of hepatitis B: clinical and virological characteristics, and response to interferon.
Boglione L; Cusato J; Cariti G; Di Perri G; D'Avolio A
J Infect; 2014 Jul; 69(1):81-7. PubMed ID: 24631900
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells contribute to hepatic injury and help in viral persistence during progression of hepatitis B e-antigen-negative chronic hepatitis B virus infection.
Ghosh S; Nandi M; Pal S; Mukhopadhyay D; Chakraborty BC; Khatun M; Bhowmick D; Mondal RK; Das S; Das K; Ghosh R; Banerjee S; Santra A; Chatterjee M; Chowdhury A; Datta S
Clin Microbiol Infect; 2016 Aug; 22(8):733.e9-733.e19. PubMed ID: 27208430
[TBL] [Abstract][Full Text] [Related]
20. Association of γδ T Cell Compartment Size to Disease Activity and Response to Therapy in SLE.
Ma H; Yuan Y; Zhao L; Ye Z; Xu J; Li M; Jiang Z; Jiang Y
PLoS One; 2016; 11(6):e0157772. PubMed ID: 27333282
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
